Home > Money > Report

Lupin moves to block rival generics

K V Ramana / DNA
Wednesday, November 25, 2009 3:15 IST
Email Email
Print Print
Share Share

Hyderabad: Pharma major Lupin Ltd is all set to block its rivals from foraying into the US market to sell antibiotic cefixime in oral suspension form. The company has approached the US Food and Drug Administration (FDA) with a citizen's petition (CP) asking the regulator to approve the generic form of Suprax (cefixime) by applying the same standards of evaluation as were applied while approving the Lupin's generic version of the drug.

Shopping therapy
It was a celebrity deluge at the seventh edition of Mana Shetty and Sharmilla Khanna's all-day shopping fest Araaish at Worli.
UK throws gauntlet, students pick it up
The UK has laid down a new law for foreign students wishing to study on the island, but that has not stopped a large number of young Bangaloreans from heading there.

Get daily news in your inbox and read it at your convenience.

D 910